Bharat Biotech

AIIMS unable to find required volunteers for Phase 3 trial of Bharat Biotech’s COVID vaccine, says officials

By Palak Vaghela 18 Dec 2020

India: Coronavirus vaccine ‘Covaxin’ shows strong immune response in its 1st phase clinical trials

<p>India’s indigenous coronavirus vaccine, Covaxin, has shown to generate strong immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad based Bharat Biotech and ICMR has been found to be safe generating no serious […]</p>

By Palak Vaghela 17 Dec 2020

Share LinkedIn

India

Bharat Biotech starts human trial for COVAXIN

<p>The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij said. The minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. Doctors at the Rohtak PGIMS, meanwhile, told reporters that three […]</p>

By Palak Vaghela 18 Jul 2020

Share LinkedIn

Web Stories